CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 58 filers reported holding CYTOSORBENTS CORP in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $846,000 | +52251.5% | 450,000 | 0.0% | 0.90% | -43.0% |
| Q2 2023 | $1,616 | +6.5% | 450,000 | 0.0% | 1.58% | -12.5% |
| Q1 2023 | $1,517 | +106.1% | 450,000 | -5.3% | 1.80% | +104.9% |
| Q4 2022 | $736 | -99.9% | 475,000 | -29.6% | 0.88% | -14.2% |
| Q3 2022 | $918,000 | -30.1% | 675,000 | +12.5% | 1.02% | -26.7% |
| Q2 2022 | $1,314,000 | +17.6% | 600,000 | +71.4% | 1.40% | +49.0% |
| Q1 2022 | $1,117,000 | -11.1% | 350,000 | +16.7% | 0.94% | -1.3% |
| Q4 2021 | $1,257,000 | -11.5% | 300,000 | +71.4% | 0.95% | -10.4% |
| Q3 2021 | $1,421,000 | +25.4% | 175,000 | +16.7% | 1.06% | +29.4% |
| Q2 2021 | $1,133,000 | +8.7% | 150,000 | +25.0% | 0.82% | +5.8% |
| Q1 2021 | $1,042,000 | – | 120,000 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |